Stay updated with breaking news from Human Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
After 48 weeks of treatment with survodutide, patients demonstrated histological improvement, a reduction in liver fat content, and did not experience worsening fibrosis.
Boehringer Ingelheim, a leading pharmaceutical firm, has transferred of manufacturing operations of one of its innovative medicines for the treatment of type 2 diabetes to Alpha Pharma in Saudi Arabia.
Boehringer Ingelheim, one of the world’s leading pharmaceutical companies, announced on Thursday (Feb 8) the transfer of manufacturing operations of one of its innovative medicines for the treatment of type 2 diabetes to Alpha Pharma in Saudi Arabia.
Boehringer Ingelheim has been awarded “Global Top Employer” for the fourth year in a row, and one of the 17 globally certified companies by the Top Employers Institute. This recognition has extended across the ASEAN, South Korea, Australia, and New Zealand (ASKAN) region. The 2024 certification reflects the impact of…
BANGKOK, Jan. 18, 2024 /PRNewswire/ -- Boehringer Ingelheim has been awarded "Global Top Employer" for the fourth year in a row, and one of the 17 globally